![Suven Life Sciences Limited logo](/logos/SUVEN.NS.webp)
Suven Life Sciences Limited
NSE:SUVEN.NS
Overview | Financials
Company Name | Suven Life Sciences Limited |
Symbol | SUVEN.NS |
Currency | INR |
Price | 150.57 |
Market Cap | 32,835,402,180 |
Dividend Yield | 0% |
52-week-range | 60.75 - 161 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Venkateswarlu Jasti M.Pharm. M.S. |
Website | https://www.suven.com |
An error occurred while fetching data.
About Suven Life Sciences Limited
Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities (NCEs) in central nervous system therapies.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD